AI Day1 LLC
SEC insider (Form 3/4/5 filer). CIK 0001863302. 10% Owner at Day One Biopharmaceuticals, Inc. (DAWN). 2 reported Form 4/5 transactions since Sep 2024; latest on Apr 23, 2026. Located in NEW YORK, NY.
Companies AI Day1 LLC has filed insider reports for
- Day One Biopharmaceuticals, Inc. (DAWN): 10% Owner
AI Day1 LLC
CIK: 0001863302
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DAWN
Day One Biopharmaceuticals, Inc.
10% Owner